Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$1.14B |
| 2 |
AbbVie
ABBV
|
+$537M |
| 3 |
T-Mobile US
TMUS
|
+$504M |
| 4 |
Baidu
BIDU
|
+$474M |
| 5 |
Kroger
KR
|
+$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$504M |
| 5 |
Humana
HUM
|
+$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Friedman Industries
FRD
$149M
| $2.52M | ﹤0.01% |
499,619
+9,399
| +2% | +$47.5K |
|
2052
MBIA
MBI
$393M
| $2.52M | ﹤0.01% |
347,492
-438,300
| -56% | -$3.18M |
|
2053
Envela
ELA
$183M
| $2.52M | ﹤0.01% |
412,717
+192,623
| +88% | +$1.18M |
|
|
GPL
2054
DELISTED
Great Panther Mining Limited
GPL
| $2.51M | ﹤0.01% |
502,337
+154,360
| +44% | +$772K |
|
|
IO
2055
DELISTED
ION Geophysical Corporation
IO
| $2.51M | ﹤0.01% |
1,073,367
-24,030
| -2% | -$56.2K |
|
|
SA
2056
Seabridge Gold
SA
$1.92B
| $2.51M | ﹤0.01% |
+143,162
| New | +$2.51M |
|
2057
FMC
FMC
$4.79B
| $2.51M | ﹤0.01% |
+25,200
| New | +$2.51M |
|
|
LBC
2058
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.5M | ﹤0.01% |
250,368
-3,100
| -1% | -$31K |
|
|
CRHM
2059
DELISTED
CRH Medical Corporation
CRHM
| $2.5M | ﹤0.01% |
1,205,485
-348,500
| -22% | -$722K |
|
2060
Peoples Financial Services
PFIS
$525M
| $2.5M | ﹤0.01% |
65,381
-14,500
| -18% | -$554K |
|
2061
Arlo Technologies
ARLO
$1.82B
| $2.5M | ﹤0.01% |
967,230
+287,630
| +42% | +$742K |
|
|
LEJU
2062
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $2.5M | ﹤0.01% |
136,315
+6,719
| +5% | +$123K |
|
|
PRNB
2063
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.49M | ﹤0.01% |
41,700
-92,400
| -69% | -$5.52M |
|
2064
Navient
NAVI
$1.28B
| $2.49M | ﹤0.01% |
+354,300
| New | +$2.49M |
|
2065
DLH Holdings
DLHC
$79.1M
| $2.49M | ﹤0.01% |
339,168
+53,841
| +19% | +$395K |
|
2066
Atlantic Union Bankshares
AUB
$5.05B
| $2.49M | ﹤0.01% |
107,394
-182,008
| -63% | -$4.21M |
|
|
OPTN
2067
DELISTED
OptiNose
OPTN
| $2.49M | ﹤0.01% |
22,280
+7,387
| +50% | +$824K |
|
2068
Arcos Dorados Holdings
ARCO
$1.43B
| $2.48M | ﹤0.01% |
609,027
+30,335
| +5% | +$124K |
|
2069
Coca-Cola Consolidated
COKE
$10.6B
| $2.48M | ﹤0.01% |
108,270
+89,270
| +470% | +$2.05M |
|
2070
Cue Biopharma
CUE
$57M
| $2.48M | ﹤0.01% |
101,000
+20,607
| +26% | +$505K |
|
|
TSC
2071
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.47M | ﹤0.01% |
157,100
-184,523
| -54% | -$2.9M |
|
2072
Citizens
CIA
$274M
| $2.47M | ﹤0.01% |
411,800
-45,800
| -10% | -$274K |
|
|
SRGA
2073
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.47M | ﹤0.01% |
25,859
-8,424
| -25% | -$804K |
|
2074
Galicia Financial Group
GGAL
$4.81B
| $2.46M | ﹤0.01% |
+253,700
| New | +$2.46M |
|
2075
scPharmaceuticals
SCPH
$302M
| $2.46M | ﹤0.01% |
333,686
+141,200
| +73% | +$1.04M |
|